AJAntoinette de Jong

Antoinette de Jong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Antoinette de Jong has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • 89Zr-rituximab PET/CT to detect neurolymphomatosis

    by Antoinette de Jong, Rogier Mous, Guus A.M.S. van Dongen, Otto S. Hoekstra, Rutger A.J. Nievelstein, Bart de Keizer


  • Computed Tomography Observer Agreement in Staging Malignant Lymphoma

    by Antoinette de Jong, Thomas C. Kwee, Henriëtte M.E. Quarles van Ufford, Frederik J.A. Beek, Lorentz G.B.A. Quekel, John M.H. de Klerk, Josée M. Zijlstra, Rob Fijnheer, Inge Ludwig, Marie José Kersten, et al.

    Objective To determine pretreatment computed tomography observer agreement in patients with newly diagnosed lymphoma. Methods Forty-nine computed tomography scans were reviewed by 3 experienced radiologists, with each scan assessed twice by 1 observer. Predefined nodal and extranodal regions were assessed, and Ann Arbor stages were assigned. K-statistics were defined as poor ( < 0.2), fair ( > 0.2 to 0.4), moderate ( > 0.4 to 0.6), substantial ( > 0.6 to 0.8), and almost perfect ( > 0.8 to 1). Results Nodal interobserver agreement varied from 0.09 for infraclavicular involvement to 0.95 for para-iliac involvement; intraobserver agreement was substantial to almost perfect, except for infraclavicular nodes. Extranodal interobserver agreement varied from 0.56 to 0.88; intraobserver agreement was substantial to almost perfect. Ann Arbor stage interobserver agreement varied from 0.57 to 0.69; intraobserver agreement was substantial. Conclusion Computed tomography observer agreement in staging malignant lymphoma appears to be suboptimal.


    • 25 April 2014
      • Vol. 4  (3) , 231-8

    Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma.

    by Antoinette De Jong, Thomas C Kwee, John M H De Klerk, Judit A Adam, Bart De Keizer, Rob Fijnheer, Marie José Kersten, Inge Ludwig, Yvonne W S Jauw, Josée M Zijlstra, et al.

    The purpose of this study was to determine the correlation between the (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) standardized uptake value (SUV) and the diffusion-weighted magnetic resonance imaging (MRI) apparent diffusion coefficient (ADC) in newly diagnosed diffuse large B-cell lymphoma (DLBCL). Pretreatment FDG-PET and diffusion-weighted MRI of 21 patients with histologically proven DLBCL were prospectively analyzed. In each patient, maximum, mean and peak standardized uptake value (SUV) was measured in the lesion with visually highest FDG uptake and in the largest lesion. Mean ADC (ADCmean, calculated with b-values of 0 and 1000 s/mm(2)) was measured in the same lesions. Correlations between FDG-PET metrics (SUVmax, SUVmean, SUVpeak) and ADCmean were assessed using Pearson's correlation coefficients. In the lesions with visually highest FDG uptake, no significant correlations were found between the SUVmax, SUVmean, SUVpeak and the ADCmean (P=0.498, P=0.609 and P=0.595, respectively). In the largest lesions, there were no significant correlations either between the SUVmax, SUVmean, SUVpeak and the ADCmean (P=0.992, P=0.843 and P=0.894, respectively). The results of this study indicate that the glycolytic rate as measured by FDG-PET and changes in water compartmentalization and water diffusion as measured by the ADC are independent biological phenomena in newly diagnosed DLBCL. Further studies are warranted to assess the complementary roles of these different imaging biomarkers in the evaluation and follow-up of DLBCL.